Synthesis of Purinyl homo-Carbonucleoside Derivatives of 2-Benzylcyclopenta[c]pyrazol

Abstract

The first members of a new class of carbocyclic nucleoside analogs were synthesized via key intermediate (±)-(cis)-2-bencylcyclopenta[c]pyrazole-4,6-dimethanol, which was obtained from the easily prepared starting compound (±)-(exo,exo)-5,6-isopropylidenedioxy-4,5,6,7-tetrahydro-4,7-methano-2H-indazole by a reaction sequence in which the key step was a one-pot oxidative cleavage of glycol 9 and reduction of the resulting dialdehyde with NaBH₄. Purine moieties were coupled by nucleophilic displacement following mesylation of the latter. The new compounds 15 and 17 are active against cytomagalovirus and varicella-zoster virus at subcytotoxical concentrations.

methanoindazoles - purinyl carbonucleosides - antiviral activity - benzylcyclopenta[c]pyrazol - glycol cleavage

References

1a Borthwick AD. Biggadike K. Tetrahedron  1992,  48:  571 

1b Agrofoglio L. Suhas E. Farese A. Condom R. Challand SR. Earl RA. Guedj R. Tetrahedron  1994,  50:  10611 

1c Huryn D. Okabe M. Chem. Rev.  1992,  92:  1745 

1d Mansour TS. Storer R. Curr. Pharm. Des.  1997,  3:  227 

1e Ichikewa E. Kato K. Curr. Med. Chem.  2001,  8:  385 

2a Marquez V. Lim M. Med. Res. Rev.  1986,  6:  1 

2b Roberts S. Biggadike K. Borthwick AD. Kirk B. In Topics in Medicinal Chemistry   Leeming PR. Royal Society of Chemistry; London: 1988.  p.172 

3a Shealy YF. Clayton JD. J. Am. Chem. Soc.  1966,  88:  3885 

3b Shealy YF. Clayton JD. J. Am. Chem. Soc.  1969,  91:  3075 

3c Shealy YF. Clayton JD. J. Pharm. Sci.  1973,  62:  1432 

4a Crimmins MT. Tetrahedron  1998,  54:  9229 

4b Zhu XF. Nucleosides, Nucleotides Nucleic Acids  2000,  19:  297 

5 Crimmins MT. King BW. J. Org. Chem.  1996,  61:  4192 

6a Daluge SM. Good SS. Faletto MB. Miller WH. Wayne H. St. Clair MH. Boone LR. Tisdale M. Parry NR. Reardon JE. Dornsife RE. Averett DR. Krenitsky TA. Antimicrob. Agents Chemother.  1997,  41:  1082 

6b Faletto MB. Miller WH. St. Clair EP. Garvey MH. Daluge SM. Good SS. Antimicrob. Agents Chemother.  1997,  41:  1099 

6c Foster RH. Faulds D. Drugs  1998,  53:  729 

7 Lea A. P., Faulds D.; Drugs; 1996, 51: 846

8 Fernández F. García-Mera X. Morales M. Rodríguez-Borges JE. Synthesis  2001,  239 

9 Fernández F. García-Mera X. Morales M. Rodríguez-Borges JE. De Clercq E. Synthesis  2002,  1084 

10 López C. Caamaño O. Hergueta AR. Fernández F. García MD. Tetrahedron Lett.  2002,  43:  5311 

11 García MD. Caamaño O. Fernández F. Figueira MJ. Gómez G. Synthesis  2003,  2138 

12a Mitsunobu O. Synthesis  1981,  1 

12b Hughes DL. In Organic Reactions   Vol. 42:  Paquette LA. John Wiley and Sons; New York: 1992.  p.344 

13

Hydrazine hydrate (3.6 mL, 19.72 mmol) was added under argon to a well-stirred solution of freshly prepared (exo,exo)-3-(hydroxymethylene)-5,6-isopropylidenedioxy)bicyclo-[2.2.1]heptan-2-one [20] (3.46 g, 16.48 mmol) in anhyd toluene (150 mL) containing a small amount of TsOH as catalyst, and the mixture was refluxed for 12 h in a Dean-Stark apparatus. The solvent was evaporated under reduced pressure and the red solid residue (3.41 g) was purified by chromatography on a silica gel column using hexane-EtOAc (1:1) as eluent. Compound 6 was isolated from appropriate fractions as a white solid (2.28 g, 67%), with mp and spectroscopic features identical to those previously described. [11]

14a Elguero J. Marzin C. Katritzky AR. Linda P. The Tautomerism of Heterocycles   Academic Press; New York: 1976.  p.29 

14b Elguero J. Marzin C. Katritzky AR. Linda P. The Tautomerism of Heterocycles   Academic Press; New York: 1976.  p.266 

14c Elguero J. Marzin C. Katritzky AR. Linda P. The Tautomerism of Heterocycles   Academic Press; New York: 1976.  p.412 

15 Martínez A. Jimeno ML. Elguero J. New J. Chem.  1994,  18:  269 

16 Kotsuki H. Wakao M. Hayakawa H. Shimanouchi T. Shiro M. J. Org. Chem.  1996,  61:  8915 

17

The crystallographic data of 10 and 18 have been deposited at the Cambridge Crystallographic Data Centre as Supplementary Publications CCDC 240518 and CCDC 240519 respectively. Copies of the data can be obtained free of charge on application to CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK.

18 Hossain N. Blaton N. Peeters O. Rozenski J. Herdewijn PA. Tetrahedron  1996,  52:  5563 

19a De Clercq E. In In vitro and ex vitro test systems to rationalize drug design and delivery   Symposium organized by Association de Pharmacie Galénique Industrielle (AGPI) and International Pharmaceutical Federation (FIP); Paris: 13 and 14 December 1993. 

19b Crommelin D. Couvreur P. Duchêne D. Editions de Santé: Paris, France  1994,  108 

20 Saksena AK. McPhail AT. Onan KD. Tetrahedron Lett.  1981,  22:  2067